oa Southern African Journal of Infectious Diseases - Characterisation of DHPS genotypes using a simple, inexpensive restriction fragment length polymorphism analysis : original research

Volume 30, Issue 2
  • ISSN : 2312-0053



is an opportunistic fungal pathogen in immunocompromised patients, causing a life-threatening disease, pneumonia (PCP). The introduction of highly active antiretroviral therapy (HAART) has significantly reduced the incidence of the disease; however, PCP remains one of the leading causes of pneumonia in immunosuppressed patients, especially in developing countries. The drug of choice for PCP treatment is trimethoprim-sulfamethoxazole. However, the widespread use of this drug has raised concerns regarding possible resistance due to dihydropteroate synthase (DHPS) mutations in infected patients. Molecular epidemiological studies are needed to estimate the prevalenceof mutant DHPS genotypes in PCP patients. We characterised genetic polymorphisms in the DHPS region of using a rapid, cost-effective restriction fragment length polymorphism (RFLP) method. We used a nested PCR to amplify a DHPS fas gene segment, followed by digestion of the product with restriction endonucleases and that identified the presence of DHPS mutations at codons 55 and 57 respectively. A total of 671 samples from 585 patients was characterised by RFLP, with an overall 87% prevalence of DHPS mutations. Most samples had single mutations (50%), 28% had double mutations and the remaining (22%) showed mixed genotypes that could not be resolved by RFLP. These significant results highlight the need for ongoing molecular epidemiological studies on the relationship between DHPS mutants and sulfa drug resistance.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error